ESC 365 - Prospective assessment of risk factors for appropriate ICD intervention in patients with ischemic cardiomyopathy: results of PARCADIA trial

ESC Premium Access

Prospective assessment of risk factors for appropriate ICD intervention in patients with ischemic cardiomyopathy: results of PARCADIA trial

Session: Ventricular arrhythmias: novel insights

Topic: Risk Factors and Risk Assessment

Speaker: Mr L. Voorhout (Arnhem, NL)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Mr Leonard Voorhout

Rijnstate Hospital, Arnhem (Netherlands (The))

0 follower

8 more presentations in this session

The relative importance of ischaemia and scar in the genesis of ventricular arrhythmia in ischaemic cardiomyopathy

Speaker: Doctor H. Morgan (London, GB)

Mineralocorticoid receptor antagonist therapy in patients with ischemic heart failure and ventricular tachycardia: a comparative analysis of spironolactone vs. eplerenone

Speaker: Doctor I. Szakal (Budapest, HU)

Predictor of wasted implantable cardioverter defibrillator for secondary prevention

Speaker: Doctor R. Akagawa (Niigata, JP)

Right ventricular outflow tract arrhythmias in patients with obstructive sleep apnea- electrophysiological insights

Speaker: Doctor A. Negru (Timisoara, RO)

Low levels of apolipoprotein M are associated with increased risk of ventricular arrhythmias

Speaker: Associate Professor P. Myhre (Nordbyhagen, NO)

Access the full session

Ventricular arrhythmias: novel insights

Speakers: Mr L. Voorhout, Doctor H. Morgan, Doctor I. Szakal, Doctor R. Akagawa, Doctor A. Negru...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources